chloramphenicol has been researched along with methyldopa in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (31.82) | 18.7374 |
1990's | 1 (4.55) | 18.2507 |
2000's | 5 (22.73) | 29.6817 |
2010's | 9 (40.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Girdwood, RH | 1 |
Hirota, Y | 1 |
Keiser, G | 1 |
Cotzias, GC; Mena, I; Tang, LC | 1 |
Fossati, C | 1 |
Pisciotta, AV | 1 |
Uhlír, O | 1 |
5 review(s) available for chloramphenicol and methyldopa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drugs and blood].
Topics: Adolescent; Adult; Agranulocytosis; Anemia, Aplastic; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Chloramphenicol; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Methyldopa; Phenothiazines; Pyrazoles; Thrombocytopenia | 1985 |
Effects of inhibitors and stimulators of protein synthesis on the cerebral actions of L-dopa.
Topics: Animals; Behavior, Animal; Brain; Caudate Nucleus; Chloramphenicol; Cycloheximide; Dactinomycin; Dihydroxyphenylalanine; Growth Hormone; Male; Methyldopa; Mice; Motor Activity; Nerve Tissue Proteins; Niacinamide; Puromycin; Time Factors | 1973 |
[Liver damage due to drugs. I].
Topics: Arsenicals; Chemical and Drug Induced Liver Injury; Chloramphenicol; Cholestasis; Coumarins; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Halothane; Humans; Imipramine; Liver; Methotrexate; Methyldopa; Nicotinic Acids; Oxacillin; Phenylbutazone; Testosterone; Tetracycline | 1974 |
Idiosyncratic hematologic reactions to drugs.
Topics: Agranulocytosis; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Macrocytic; Aspirin; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Cell Differentiation; Cell Division; Cephalothin; Chloramphenicol; Coombs Test; Drug Hypersensitivity; Erythrocytes; Humans; Methyldopa; Penicillins; Phenytoin; Purpura, Thrombocytopenic; Quinidine | 1974 |
17 other study(ies) available for chloramphenicol and methyldopa
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Haematological side-effects of drugs.
Topics: Ampicillin; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Megaloblastic; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Chloramphenicol; Chlorpromazine; Gastrointestinal Hemorrhage; Glucosephosphate Dehydrogenase; Hematologic Diseases; Hemorrhage; Humans; Leukopenia; Methyldopa; Oxyphenbutazone; Purpura, Thrombocytopenic | 1976 |
[Hemopoietic disorder caused by drugs--special significance placed on anemia].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Megaloblastic; Anemia, Sideroblastic; Chloramphenicol; Ethanol; Humans; Methotrexate; Methyldopa; Middle Aged; Neomycin; Penicillins; Phenacetin; Phenobarbital | 1991 |
Editorial: Drug-induced blood dyscrasias.
Topics: Adult; Age Factors; Analgesics; Child; Chloramphenicol; Diuretics; Female; Hematologic Diseases; Humans; Male; Methyldopa | 1973 |
[Results of monitoring of adverse drug effects in various European countries in the years 1967-1969].
Topics: Aerosols; Appetite Depressants; Chloramphenicol; Contraceptives, Oral; Czechoslovakia; Dextrans; Drug-Related Side Effects and Adverse Reactions; Ethacrynic Acid; Europe; Halothane; Lithium; Methyldopa; Methysergide; Nalidixic Acid; Parasympatholytics; Penicillins; Phenothiazines; Sulfonamides | 1970 |